CD4 and neoplasm: These clonal dynamics, coupled with subset-specific interactions (e.g., tumor-associated atypical B cells with CD4+ T cells via MHC-II), shape B cells’dual roles in humoral immunity and T cell regulation, with implications for antitumor immunity, immune evasion, and immunotherapy response (1).